Skip to main content
Toggle navigation
Login
Search
Home
Home
Type here to filter the list
Thursday, Nov 13th
1:15 PM - 2:15 PM
EST
Hematopathology Plenary
Location: Grand Ballroom, Level 3
Program Committee Moderator:
Amir Behdad, MD, MBA (he/him/his)
– Cleveland Clinic Florida
Program Committee Moderator:
Joanna Conant, MD (she/her/hers)
– ~
CE: 1.0
Thursday, Nov 13th
1:15 PM - 2:15 PM
EST
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Location: Grand Ballroom, Level 3
Plenary Speaker:
C. Ola Landgren, MD, PhD (he/him/his)
– University of Miami, Sylvester Comprehensive Cancer Center
CE: 1.0
Thursday, Nov 13th
2:30 PM - 3:30 PM
EST
AMP Working Group: Molecular Testing for Measurable Residual Disease Testing in Acute Myeloid Leukemia
Location: 156ABC, Level 1
Working Group Moderator:
Rena R. Xian, MD (she/her/hers)
– Johns Hopkins University School of Medicine
CE: 1.0
Thursday, Nov 13th
2:30 PM - 3:30 PM
EST
AMP Working Group: Molecular Testing for Measurable Residual Disease Testing in Acute Myeloid Leukemia
Location: 156ABC, Level 1
Working Group Speaker:
Keyur P. Patel, MD PhD
– University of Texas MD Anderson Cancer Center
Working Group Panelist:
Noah Brown, MD
– University of Michgian
Working Group Panelist:
Rashmi Goswami, MD, PhD (she/her/hers)
– University of Toronto
CE: 1.0
Friday, Nov 14th
10:15 AM - 11:00 AM
EST
Rapid Epigenomic Classification of Acute Leukemia
Location: 157ABC, Level 1
Breakout Speaker:
Gabriel Griffin, MD (he/him/his)
– Dana-Farber Cancer Institute
CE: 1.5
Friday, Nov 14th
11:00 AM - 11:45 AM
EST
Rapid Epigenomic Classification of Acute Leukemia
Location: 157ABC, Level 1
Breakout Speaker:
Volker Hovestadt, PhD (he/him/his)
– Dana-Farber Cancer Institute
CE: 1.5
Friday, Nov 14th
1:15 PM - 2:00 PM
EST
DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma
Location: 156ABC, Level 1
Breakout Speaker:
Christopher Oakes, PhD
– The Ohio State University
CE: 1.5
Friday, Nov 14th
2:00 PM - 2:45 PM
EST
Fluctuating DNA methylation and evolutionary history in lymphoid cancers
Location: 156ABC, Level 1
Breakout Speaker:
Trevor Graham, PhD
– Institute of Cancer Research, London, UK
CE: 1.5
Saturday, Nov 15th
10:15 AM - 11:00 AM
EST
Optimizing Molecular Testing and Reporting for Myeloid Malignancies: Bridging Oncologist Expectations with Laboratory Practicalities (Panel discussion)
Location: 157ABC, Level 1
Breakout Speaker:
Annette S. Kim, MD, PhD (she/her/hers)
– University of Michigan
CE: 1.5
Saturday, Nov 15th
11:00 AM - 11:45 AM
EST
Optimizing Molecular Testing and Reporting for Myeloid Malignancies: Bridging Oncologist Expectations with Laboratory Practicalities (Panel Discussion)
Location: 157ABC, Level 1
Breakout Speaker:
Marlise R. Luskin, MD MSCE (she/her/hers)
– Dana-Farber Cancer Institute
CE: 1.5
Saturday, Nov 15th
1:15 PM - 2:15 PM
EST
AMP Working Group: Application of NGS of Immunoglobulin Heavy Chain and T-cell Receptor Gamma Gene Rearrangements for Clonality Assessment in Lymphoid Malignancies
Location: 153ABC, Level 1
Working Group Speaker:
DAVID VISWANATHA, MD
– Mayo Clinic-Rochester
Working Group Panelist:
Maria E. Arcila, MD
– Memorial Sloan Kettering Cancer Center
Working Group Panelist:
Tim C. Greiner, MS, MD
– University of Nebraska Medical Center
CE: 1.0